This Is What CKD Care 4.0 Looks Like

Carna Health Logo

Carna Health and Renalytix™ announce partnership to bridge gap between population screening and precision intervention.

Read more
CKM CARE · AI-POWERED PLATFORM

Detecting the Undetectable.
At Population Scale.

Carna is the AI-driven platform public and private healthcare systems deploy to detect, manage, and prevent Cardio-Kidney Metabolic syndrome.

Get Started

#12

Healthcare Sector

FORTUNE · AMERICA'S MOST INNOVATIVE COMPANIES 2026

Ranked Among America's Most Innovative Companies

Evaluated alongside Alphabet (#1), Microsoft (#2), Nvidia (#7), and OpenAI (#66) — out of 300 companies globally.

#70

Overall Rank

Top 1%

All Companies Globally

300

Companies Ranked

INCREASING prevalence OF CHRONIC DISEASE

What We Are Solving in Global Healthcare

Awareness

90% of CKD patients are completely unaware of their condition. Without proactive screening programs and patient engagement tools, communities remain blind to a disease that has no symptoms until it's too late to prevent catastrophic outcomes.

Access

Point-of-care testing infrastructure is absent in most primary care settings. Without scalable, affordable diagnostics and predictive analytics, health systems can't find disease early — especially in low-resource and rural communities.

Fragmentation

CKM management requires coordinated care across primary care, nephrology, cardiology, and endocrinology — but most systems operate in silos. Without shared data and integrated pathways, patients fall through the gaps.

Our platform

AI-Powered Detection & Management, Deployed at Population Scale

The only end-to-end CKM screening platform — combining FDA-cleared point-of-care devices with AI that identifies who will progress and routes them to care.
Early Detection

FDA-cleared POCT devices. eGFR & uACR in under 15 minutes — no lab or specialist required. Deployable in hospitals, clinics, pharmacies, or rural community centers.

AI Predictive Analytics

Identifies which screened patients will likely progress to advanced CKD — before deterioration. Flags high-risk individuals and generates targeted referral pathways in real-time.

AI Upskilling

AI-guided workflows empower nurses, pharmacists, and primary care providers to manage complex CKM cases — without specialist referral. Closes the global specialist gap.

Seamless Interoperability

Universal data ingestion from POCT, labs, EHR, HIEs, wearables, and SDoH sources. Leveraging FHIR / HL7 / API for faster integration with client systems

Strategic Partnerships

Siemens Healthineers
Exclusive POC Device Integration · 70+ Countries
Renalytix
FDA-Approved Predictive Diagnostics for Kidney Risk
NeoDocs
Next-Generation Instant Diagnostic Solutions
DiME
Global Non-Profit for Digital Medicine Adoption
CES
Global Stage for Next-Gen Tech Innovation
OUR IMPACT

Meaningful Transformation for Chronic Disease

Carna Health is at the forefront of chronic disease innovation, merging groundbreaking technology with a deep commitment to patient care.

in the spotlight

Carna Health's Latest News

Salvatore G. Viscomi, MD
CEO & Co - Founder

It's time for a novel approach to transform chronic disease prevention and management. As a physician executive and founder of Carna Health, I am immensely proud of the digital platform we've developed to disrupt the trajectory of these diseases. Our solution enhances patient awareness, provides accessible testing, and guides both patients and healthcare providers toward the right interventions. Leveraging AI, our platform improves risk assessment and optimizes treatment, simultaneously upskilling care teams to ensure better health outcomes.